fbpx

ALK-Abelló A/S

alk

ALK-Abelló A/S is an international pharmaceutical company devoted to improve the lives of people with allergies by developing pharmaceuticals products that target the cause of allergy.

ALK-Abelló A/S is the world leader in allergy vaccination (immunotherapy) – a unique treatment including a protective immune response that reduces and potentially halts the allergic reaction.

For further information: www.alk.net

Lundbeckfonden

News

The Lundbeck Foundation seeks greater diversity among grant recipients and prizewinners
1. May 2019
Deep dive in the deadly chemistry of snakebites
26. April 2019
Share your most audacious research idea with us
25. April 2019